IUPAC/Chemical Name
4'-(3-(4-(o-Fluorophenyl)-1-piperazinyl)propoxy)-m-acetanisidide
InChi Key
PHOCQBYGUQPMIB-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H28FN3O3/c1-17(27)24-18-8-9-21(22(16-18)28-2)29-15-5-10-25-11-13-26(14-12-25)20-7-4-3-6-19(20)23/h3-4,6-9,16H,5,10-15H2,1-2H3,(H,24,27)
SMILES Code
CC(NC1=CC=C(OCCCN2CCN(C3=CC=CC=C3F)CC2)C(OC)=C1)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
401.48
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Yamamura M, Nakagawa H, Maeda K, Kinoshita K, Ishida R. Effects of mafoprazine, a phenylpiperazine derivative, on the central dopaminergic system. Jpn J Pharmacol. 1989 Jul;50(3):295-305. PubMed PMID: 2569544.
2: Yamamura M, Nakagawa H, Kinoshita K, Ochiai T, Ishida R. A behavioral pharmacological study of mafoprazine, a new phenylpiperazine derivative. Jpn J Pharmacol. 1988 Oct;48(2):203-12. PubMed PMID: 3210446.
3: Fukuchi I, Kawashima K, Matsuoka Y, Ishida R. Neurochemical study of mafoprazine, a new phenylpiperazine derivative. Jpn J Pharmacol. 1988 May;47(1):51-61. PubMed PMID: 3411821.
4: Rao TS, Mick SJ, Cler JA, Emmett MR, Dilworth VM, Contreras PC, Gray NM, Wood PL, Iyengar S. Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands. Brain Res. 1991 Oct 4;561(1):43-50. PubMed PMID: 1686745.